News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Egetis to participate at upcoming investor conferences

August 30, 2023

Stockholm, Sweden, August 30, 2023. Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today announced that the Company will participate at the following upcoming investor conferences:
Handelsbanken Life Science Innovation Day
August 30, 2023, virtual

Erik Penser Bank Healthcare Day
September 7, 2023, Stockholm

Pareto Annual Healthcare Conference
September 14, 2023, Stockholm

SEB Annual Healthcare Conference
November 21-23, 2023, Stockholm

Redeye Life Science Day
November 23, 2023, Stockholm

DNB Nordic Healthcare Conference
December 14, 2023, Oslo



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10